Publication: SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA trial
No Thumbnail Available
Identifiers
Date
2022-05-05
Authors
Balmana, J.
Pascual, T.
Llop-Guevara, A.
Tolosa, P.
Blancas Lopez-Barajas, I.
Perez Lopez, M. E.
Adamo, B.
Teruel-Garcia, I.
Ponce, J.
Gonzalez-Cordero, M.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
